Management of Stable Angina - Current Guidelines: A Critical Appraisal

Area of Science:

• Cardiology
• Clinical Practice Guidelines
• Evidence-Based Medicine

Background:

• Current guidelines for stable angina often base recommendations on expert opinion rather than empirical evidence.
• There is significant international variation in guideline recommendations for optimal antianginal treatment.
• The management of stable angina, particularly in patients with normal coronary arteries, remains unclear.

Purpose of the Study:

• To critically appraise existing guideline recommendations for managing stable angina pectoris.
• To identify areas where treatment strategies lack strong evidence-based support.
• To highlight discrepancies in recommendations across different international guidelines.

Main Methods:

• Critical review of current international guidelines for stable angina management.
• Analysis of the evidence base supporting key recommendations, including risk stratification and revascularization.
• Comparison of therapeutic approaches for antianginal drugs and statin therapy.

Main Results:

• Many recommendations for risk stratification and revascularization in stable angina are based on expert opinion, not randomized trials.
• No antianginal drugs have been proven to reduce mortality or myocardial infarction (MI), yet specific classes are preferentially recommended.
• Guidelines differ significantly on statin therapy intensity (high-dose vs. LDL-goal) for patients with ischemic heart disease.

Conclusions:

• There is a critical need to shift from opinion-based to evidence-based recommendations in stable angina management.
• Further research is required to establish optimal antianginal drug regimens and revascularization strategies.
• Clarification is needed for managing stable angina patients with normal coronary arteries and optimizing lipid-lowering therapy.